Brief: Abeona Therapeutics Announces FDA Acceptance Of BLA Resubmission Of Pz-cel For The Treatment Of Recessive Dystrophic Epidermolysis Bullosa

Abeona Therapeutics

12/11/2024 13:15

Nov 12 (Reuters) - Abeona Therapeutics Inc  ABEO.O :
    * ABEONA THERAPEUTICS® ANNOUNCES FDA ACCEPTANCE OF BLA
RESUBMISSION OF PZ-CEL FOR THE TREATMENT OF RECESSIVE DYSTROPHIC
EPIDERMOLYSIS BULLOSA
    * ABEONA THERAPEUTICS INC - FDA SETS PDUFA TARGET ACTION
DATE OF
APRIL 29, 2025
    * ABEONA THERAPEUTICS INC - BLA RESUBMISSION SUPPORTED BY
PHASE 3
AND PHASE 1/2A STUDIES
    * ABEONA THERAPEUTICS INC - MAY RECEIVE PRIORITY REVIEW
VOUCHER IF
PZ-CEL APPROVED

Source text:  ID:nGNX7xQfFl 
Further company coverage:  ABEO.O 

 ((Reuters.Briefs@thomsonreuters.com;))